107 related articles for article (PubMed ID: 19383251)
1. Microvessel density and expression of thrombospondin-1 in non-small cell lung cancer and their correlation with clinicopathological features.
Chen ZJ; Le HB; Zhang YK; Qian LY; Li WD
J Int Med Res; 2009; 37(2):551-6. PubMed ID: 19383251
[TBL] [Abstract][Full Text] [Related]
2. Expression of thrombospondin in non-small cell lung cancer.
Mascaux C; Martin B; Paesmans M; Verdebout JM; Verhest A; Vermylen P; Bosschaerts T; Ninane V; Sculier JP
Anticancer Res; 2002; 22(2B):1273-7. PubMed ID: 12168937
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer.
Yamaguchi M; Sugio K; Ondo K; Yano T; Sugimachi K
Lung Cancer; 2002 May; 36(2):143-50. PubMed ID: 11955648
[TBL] [Abstract][Full Text] [Related]
4. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density].
Han ZG; Yu TT; Shan L
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer.
Oshika Y; Masuda K; Tokunaga T; Hatanaka H; Kamiya T; Abe Y; Ozeki Y; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
Clin Cancer Res; 1998 Jul; 4(7):1785-8. PubMed ID: 9676856
[TBL] [Abstract][Full Text] [Related]
8. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
Volm M; Koomägi R; Mattern J
Anticancer Res; 1996; 16(1):213-7. PubMed ID: 8615611
[TBL] [Abstract][Full Text] [Related]
9. [Significance of caveolin-1 expression in primary lung cancer].
Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
11. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
Chang C; Wang P; Yang H; Li L; Zhang LB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte elevated gene-1 is overexpressed in non-small-cell lung cancer and associated with increased tumour angiogenesis.
Ding Q; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Ma Z
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):395-401. PubMed ID: 29049797
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry.
Bing Z; Jian-ru Y; Yao-quan J; Shi-feng C
Cell Biochem Biophys; 2014 Sep; 70(1):327-31. PubMed ID: 24676677
[TBL] [Abstract][Full Text] [Related]
14. Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Wu S; Yu L; Cheng Z; Song W; Zhou L; Tao Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):346-352. PubMed ID: 22684556
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
[TBL] [Abstract][Full Text] [Related]
16. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
[TBL] [Abstract][Full Text] [Related]
17. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.
Zhang J; Ito R; Oue N; Zhu X; Kitadai Y; Yoshida K; Nakayama H; Yasui W
Virchows Arch; 2003 Jun; 442(6):563-8. PubMed ID: 12719977
[TBL] [Abstract][Full Text] [Related]
18. Net platelet angiogenic activity (NPAA) correlates with progression and prognosis of non-small cell lung cancer.
Yao L; Dong H; Luo Y; Du J; Hu W
PLoS One; 2014; 9(4):e96206. PubMed ID: 24788022
[TBL] [Abstract][Full Text] [Related]
19. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
Maeda R; Ishii G; Ito M; Hishida T; Yoshida J; Nishimura M; Haga H; Nagai K; Ochiai A
J Thorac Oncol; 2012 Mar; 7(3):503-11. PubMed ID: 22198428
[TBL] [Abstract][Full Text] [Related]
20. [The influence of microvessel density in the tumor on the prognosis in patients with stage I-II non-small cell lung cancer after surgical treatment].
Kolesnik AP; Shevchenko AI; Tumanskiĭ VA; Evseev AV; Shishkin MA
Vopr Onkol; 2013; 59(6):735-9. PubMed ID: 24624783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]